Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TauroSept versus saline catheter lock for prevention of catheter-related bloodstream infection in home parenteral nutrition
NL-OMON36907Not yet recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of taurolidine and sodium chloride in catheter-associated bloodstream infection (CRBSI) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Mean number of catheter-related bloodstream infections per 1,000 catheter days. Planned start Jan 2013; status: not yet recruiting.
02
Drugs
taurolidinesodium chloride
03
Conditions
catheter-associated bloodstream infection (CRBSI)
Beyond the preview
Go deeper on NL-OMON36907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36907.